Your browser doesn't support javascript.
loading
Association of demographics, HCV co-infection, HIV-1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV-1 Surveillance Network.
Otani, Machiko; Shiino, Teiichiro; Hachiya, Atsuko; Gatanaga, Hiroyuki; Watanabe, Dai; Minami, Rumi; Nishizawa, Masako; Teshima, Takanori; Yoshida, Shigeru; Ito, Toshihiro; Hayashida, Tsunefusa; Koga, Michiko; Nagashima, Mami; Sadamasu, Kenji; Kondo, Makiko; Kato, Shingo; Uno, Shunsuke; Taniguchi, Toshibumi; Igari, Hidetoshi; Samukawa, Sei; Nakajima, Hideaki; Yoshino, Yusuke; Horiba, Masahide; Moro, Hiroshi; Watanabe, Tamayo; Imahashi, Mayumi; Yokomaku, Yoshiyuki; Mori, Haruyo; Fujii, Teruhisa; Takada, Kiyonori; Nakamura, Asako; Nakamura, Hideta; Tateyama, Masao; Matsushita, Shuzo; Yoshimura, Kazuhisa; Sugiura, Wataru; Matano, Tetsuro; Kikuchi, Tadashi.
Afiliação
  • Otani M; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Shiino T; Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Hachiya A; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Gatanaga H; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Watanabe D; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
  • Minami R; Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan.
  • Nishizawa M; Department of Clinical Laboratory Sciences, Nitobe Bunka College, Tokyo, Japan.
  • Teshima T; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Yoshida S; AIDS Medical Center, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Ito T; Internal Medicine, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Hayashida T; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Koga M; Department of Clinical Laboratories, Hokkaido University Hospital, Hokkaido, Japan.
  • Nagashima M; Department of Hematology, Faculty of Medicine, Hokkaido University, Hokkaido, Japan.
  • Sadamasu K; School of Medical Technology, Health Sciences University of Hokkaido, Hokkaido, Japan.
  • Kondo M; Department of Infectious Diseases, National Hospital Organization Sendai Medical Center, Miyagi, Japan.
  • Kato S; AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Uno S; Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Taniguchi T; Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
  • Igari H; Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
  • Samukawa S; Division of Microbiology, Kanagawa Prefectural Institute of Public Health, Kanagawa, Japan.
  • Nakajima H; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
  • Yoshino Y; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
  • Horiba M; Department of Infection Control, Chiba University Hospital, Chiba, Japan.
  • Moro H; Department of Infection Control, Chiba University Hospital, Chiba, Japan.
  • Watanabe T; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Kanagawa, Japan.
  • Imahashi M; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Kanagawa, Japan.
  • Yokomaku Y; Department of Microbiology, Teikyo University School of Medicine, Tokyo, Japan.
  • Mori H; Department of Respiratory Medicine, National Hospital Organization Higashisaitama National Hospital, Saitama, Japan.
  • Fujii T; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Takada K; Department of Immunology and Infectious Disease, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
  • Nakamura A; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
  • Nakamura H; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
  • Tateyama M; Division of Microbiology, Osaka Institute of Public Health, Osaka, Japan.
  • Matsushita S; Division of Transfusion Medicine, Hiroshima University Hospital, Hiroshima, Japan.
  • Yoshimura K; Postgraduate Clinical Training Center, Ehime University Hospital, Ehime, Japan.
  • Sugiura W; Division of Virology, Fukuoka Institute of Health and Environmental Sciences, Fukuoka, Japan.
  • Matano T; Department of Infectious, Respiratory, and Digestive Medicine, Control and Prevention of Infectious Diseases, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Kikuchi T; Department of Infectious, Respiratory, and Digestive Medicine, Control and Prevention of Infectious Diseases, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
J Int AIDS Soc ; 26(5): e26086, 2023 05.
Article em En | MEDLINE | ID: mdl-37221951
INTRODUCTION: Late diagnosis of the human immunodeficiency virus (HIV) is a major concern epidemiologically, socially and for national healthcare systems. Although the association of certain demographics with late HIV diagnosis has been reported in several studies, the association of other factors, including clinical and phylogenetic factors, remains unclear. In the present study, we conducted a nationwide analysis to explore the association of demographics, clinical factors, HIV-1 subtypes/circulating recombinant form (CRFs) and genetic clustering with late HIV diagnosis in Japan, where new infections mainly occur among young men who have sex with men (MSM) in urban areas. METHODS: Anonymized data on demographics, clinical factors and HIV genetic sequences from 39.8% of people newly diagnosed with HIV in Japan were collected by the Japanese Drug Resistance HIV-1 Surveillance Network from 2003 to 2019. Factors associated with late HIV diagnosis (defined as HIV diagnosis with a CD4 count <350 cells/µl) were identified using logistic regression. Clusters were identified by HIV-TRACE with a genetic distance threshold of 1.5%. RESULTS: Of the 9422 people newly diagnosed with HIV enrolled in the surveillance network between 2003 and 2019, 7752 individuals with available CD4 count at diagnosis were included. Late HIV diagnosis was observed in 5522 (71.2%) participants. The overall median CD4 count at diagnosis was 221 (IQR: 62-373) cells/µl. Variables independently associated with late HIV diagnosis included age (adjusted odds ratio [aOR] 2.21, 95% CI 1.88-2.59, ≥45 vs. ≤29 years), heterosexual transmission (aOR 1.34, 95% CI 1.11-1.62, vs. MSM), living outside of Tokyo (aOR 1.18, 95% CI 1.05-1.32), hepatitis C virus (HCV) co-infection (aOR 1.42, 95% CI 1.01-1.98) and not belonging to a cluster (aOR 1.30, 95% CI 1.12-1.51). CRF07_BC (aOR 0.34, 95% CI 0.18-0.65, vs. subtype B) was negatively associated with late HIV diagnosis. CONCLUSIONS: In addition to demographic factors, HCV co-infection, HIV-1 subtypes/CRFs and not belonging to a cluster were independently associated with late HIV diagnosis in Japan. These results imply the need for public health programmes aimed at the general population, including but not limited to key populations, to encourage HIV testing.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Hepatite C / Minorias Sexuais e de Gênero Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: J Int AIDS Soc Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Hepatite C / Minorias Sexuais e de Gênero Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: J Int AIDS Soc Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão